Received European approval to ship Annamycin into Poland to start treating patients HOUSTON, Jan. 09, 2019 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company...
– TrialSpark partners with doctors to offer clinical trials in their existing practices by providing all the training, resources, and staff needed to run investigational and observational studies. – In collaboration with TrialSpark, Novartis is pioneering...
Marjorie A. Speers, PhD, is executive director of Clinical Research Pathways writes, (excerpted) Clinical trials conducted today in the United States lean heavily toward populations that are 80-90 percent white, as reported in a recent Scientific American editorial....
Results Are Expected to Prompt Changes in Practice, Improve Patient Outcomes Three studies being presented today during the 60th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego offer more targeted solutions for managing CLL and multiple...
Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) today announced that it has passed the 50 percent enrollment point in its first pivotal Phase 3 clinical trial of RP-G28 for the potential treatment of LI, a study known as the “Liberatus” study. “We are pleased to have...
Email
Text